Eszopiclone for the Treatment of Posttraumatic Stress Disorder and Associated Insomnia
Authors:
- Mark H. PollackMPMark H. Pollack
- Elizabeth A. HogeEHElizabeth A. Hoge
- John J. WorthingtonJWJohn J. Worthington
- Samantha J. MoshierSMSamantha J. Moshier
- Rachel S. WechslerRWRachel S. Wechsler
- Mina BrandesMBMina Brandes
- Naomi M. SimonNSNaomi M. Simon
- 22 February 2011
- journal article
- research article
- Published by Physicians Postgraduate Press, Inc in The Journal of Clinical Psychiatry
- Vol. 72 (07) , 892-897
Abstract
The development of novel strategies for the treatment of posttraumatic stress disorder (PTSD) represents a critical public health need. We present the first prospective, randomized, double-blind, placebo-controlled trial of a non-benzodiazepine hypnotic agent for the treatment of PTSD and associated insomnia. Twenty-four patients with PTSD by DSM-IV criteria and sleep disturbance were treated in a randomized, double-blind, placebo-controlled crossover study of 3 weeks of eszopiclone 3 mg at bedtime compared to placebo. The primary outcome measures were changes in scores on the Short PTSD Rating Interview (SPRINT) and the Pittsburgh Sleep Quality Index (PSQI). The data were collected from April 2006 to June 2008. Three weeks of eszopiclone pharmacotherapy was associated with significantly greater improvement than placebo on PTSD symptom measures including the SPRINT (P = .032) and the Clinician-Administered PTSD Scale (P = .003), as well as on measures of sleep including the PSQI (P = .011) and sleep latency (P = .044). Greater improvement with eszopiclone on PTSD measures was present even when specific sleep-related items were excluded. Adverse events were consistent with the known profile of the drug. This study provides initial evidence that pharmacotherapy with eszopiclone may be associated with short-term improvement in overall PTSD severity as well as associated sleep disturbance. Longer, more definitive study of eszopiclone in PTSD is warranted. clinicaltrials.gov Identifier: NCT00120250.Keywords
This publication has 20 references indexed in Scilit:
- A Prospective Study of PTSD and Early-Age Heart Disease Mortality Among Vietnam Veterans: Implications for Surveillance and PreventionPsychosomatic Medicine, 2008
- Hypnotherapy in the Treatment of Chronic Combat-Related PTSD Patients Suffering From Insomnia:A Randomized, Zolpidem-Controlled Clinical TrialInternational Journal of Clinical and Experimental Hypnosis, 2008
- A Parallel Group Placebo Controlled Study of Prazosin for Trauma Nightmares and Sleep Disturbance in Combat Veterans with Post-Traumatic Stress DisorderBiological Psychiatry, 2007
- Eszopiclone Co-Administered With Fluoxetine in Patients With Insomnia Coexisting With Major Depressive DisorderBiological Psychiatry, 2006
- Antidepressants and their effect on sleepHuman Psychopharmacology: Clinical and Experimental, 2005
- Sleep disturbances in depression and the effects of antidepressantsInternational Review of Psychiatry, 2005
- REM sleep deprivation affects extinction of cued but not contextual fear conditioningPhysiology & Behavior, 2005
- Sleep and posttraumatic stress disorder: a reviewClinical Psychology Review, 2003
- Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trialBiological Psychiatry, 2003
- SLEEP-DISORDERED BREATHING, PSYCHIATRIC DISTRESS, AND QUALITY OF LIFE IMPAIRMENT IN SEXUAL ASSAULT SURVIVORSJournal of Nervous & Mental Disease, 2002